文献速递主动脉疾病

在亚阈值腹主动脉瘤患者中,体积较最大直径对随访腹主动脉瘤生长及减少监测访视的价值

The value of volume over maximum diameter for following abdominal aortic aneurysm growth and reducing surveillance visits in patients with a subthreshold aneurysm.
PubMed 文献 · J Vasc Surg · 2025-04-03

这项前瞻性观察性队列研究纳入126例接受监测的腹主动脉瘤患者,在多中心BIOMArCS-AAA研究中于基线及1年、2年行CT测量最大直径与总体积。结果显示体积对监测间期内小变化的检出更敏感,联合体积测量可使更多患者安全豁免1年影像监测,并改善2年需手术患者的识别。

要点

  • 1年随访时最大直径中位增长2.3 mm,体积中位增长10.8 mL。
  • 下次推荐监测时点尺寸变化落在观察者间变异范围内者:直径81例(65%),体积43例(34%),P < .001。
  • 单用直径可使32例(26%)豁免1年监测影像,联合体积可使其增至54例(44%),P = .002。

核心结论

  • 腹主动脉瘤体积对当前推荐监测间期内尺寸小变化的检出比最大直径更敏感,可用于安全延长小腹主动脉瘤患者的监测间期。
  • 作者认为应在研究中鼓励使用体积测量,并可能在腹主动脉瘤监测中具有价值。

研究设计与样本

  • 前瞻性观察性队列研究,纳入多中心BIOMArCS-AAA研究中126例接受监测的腹主动脉瘤患者。
  • 参与者在入组时及1年、2年接受CT扫描,同时合并临床诊疗所需的CT扫描。
  • 在中心腔线重建后测量最大直径和总体积,采用混合效应回归评估最大直径和体积随时间的变化。
  • 采用Cox模型及基于累积发生率的阳性和阴性预测值,评估体积联合最大直径区分是否发生复合终点(符合手术指征、或腹主动脉瘤破裂/腹主动脉瘤相关死亡)的价值。

主要发现

  • 每例患者中位可获得3次扫描。
  • 基线最大直径中位(第25、75百分位)为48 mm(45,52 mm),体积为109 mL(90,130 mL)。
  • 1年随访时观察到的最大直径中位(第25、75百分位)增长为2.3 mm(1.3,3.1 mm),体积增长为10.8 mL(7.0,16.4 mL)。
  • 下次推荐监测访视时动脉瘤尺寸变化落在观察者间变异范围内者:测量最大直径时为81例(65%),测量体积时为43例(34%),P < .001。
  • 单用一次最大直径测量可使32例(26%)豁免1年监测影像,同时确保符合手术指征的风险低于10%;联合同期体积测量可使54例(44%)同样安全豁免监测影像,P = .002。

临床怎么用

  • 作者认为腹主动脉瘤体积对检测当前推荐监测间期内尺寸小变化更敏感,可用于安全延长小腹主动脉瘤患者的监测间期。
  • 作者认为应在研究中鼓励使用体积测量,并可能在腹主动脉瘤监测中具有价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe and compare abdominal aortic aneurysm (AAA) volume to maximum diameter regarding follow-up of AAA progression and investigate its added value in AAA surveillance. METHODS: This prospective, observational cohort study included 126 patients enrolled in the multicenter BIOMArCS-AAA study (Study of Biomarker Profiling to Unravel the Intertwined Pathophysiology of Coronary Artery Disease and Abdominal Aortic Aneurysm) who were under surveillance for an AAA. Participants underwent computed tomography scans at study inclusion and after 1 and 2 years, alongside computed tomography scans for clinical care. Maximum diameter and total volume were measured after center lumen line reconstruction. Mixed-effects regression was used to evaluate the maximum diameter and volume changes over time. The value of volume alongside the maximum diameter to distinguish patients who will or will not experience the composite end point (qualifying for surgery, or AAA rupture/AAA-related death) was evaluated using Cox models and cumulative incidence-based positive and negative predictive values. RESULTS: A median of three scans were available per patient. The baseline median (25th, 75th percentile) maximum diameter and volume were 48 mm (45, 52 mm) and 109 mL (90, 130 mL), respectively. The observed median (25th, 75th percentile) growth at the 1-year follow-up was 2.3 mm (1.3, 3.1 mm) in maximum diameter, and 10.8 mL (7.0, 16.4 mL) in volume. Changes in aneurysm size at the next recommended surveillance visit lay within the boundaries of the interobserver variability for 81 patients (65%) when measuring maximum diameter, compared with 43 patients (34%) when measuring volume (P < .001). Using a single maximum diameter measurement, 32 patients (26%) could be exempt from surveillance imaging at 1 year, while ensuring that the risk of qualifying for surgery remains below 10%. When combining this with a simultaneous volume measurement, 54 patients (44%) could similarly be safely exempt from surveillance imaging (P = .002). Moreover, simultaneously measuring volume refines the identification of patients that will qualify for surgery at 2 years (positive predictive value diameter alone vs diameter and volume, 57.7% and 72.5%, respectively; P < .001). CONCLUSIONS: AAA volume is more sensitive to detect small changes in aneurysm size at the currently recommended surveillance intervals, and could be used to safely prolong surveillance intervals for patients with a small AAA. The use of volume should be encouraged in research and could prove valuable in AAA surveillance.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Vanmaele A, Bouwens E, Hoeks SE, et al. The value of volume over maximum diameter for following abdominal aortic aneurysm growth and reducing surveillance visits in patients with a subthreshold aneurysm. J Vasc Surg. 2025. PMID: 40187384. doi:10.1016/j.jvs.2025.03.395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。